Synergistic activation of human T cells by interleukin 1 and interleukin 6 (Q24296628)

GOA release 2020-03-11

author name string

F A Houssiau

1

0 references

P G Coulie

2

0 references

D Olive

3

0 references

J Van Snick

European Journal of Immunology

4

0 references

language of work or name

English

0 references

publication date

April 1988

0 references

published in

0 references

volume

18

0 references

issue

4

0 references

page(s)

653-6

0 references

cites work

Accessory cells provide more than one signal for lectin mitogen-stimulated proliferation of human lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Production of hybridoma growth factor by human monocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

cDNA cloning of murine interleukin-HP1: homology with human interleukin 6.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak crossreacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differenti

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Anti-interleukin 2 receptor monoclonal antibodies. Respective role of epitope mapping and monoclonal antibody-receptor interactions in their antagonist effects on interleukin 2-dependent T cell growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Molecular cloning of human interleukin 2 cDNA and its expression inE. coli

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021

B cell growth and differentiation activity of interleukin-HP1 and related murine plasmacytoma growth factors. Synergy with interleukin 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830180427

7 January 2021